Cargando…

Automated Insulin Delivery with SGLT2i Combination Therapy in Type 1 Diabetes

BACKGROUND: Use of sodium-glucose cotransporter 2 inhibitors (SGLT2i) as adjunct therapy to insulin in type 1 diabetes (T1D) has been previously studied. In this study, we present data from the first free-living trial combining low-dose SGLT2i with commercial automated insulin delivery (AID) or pred...

Descripción completa

Detalles Bibliográficos
Autores principales:	Garcia-Tirado, Jose, Farhy, Leon, Nass, Ralf, Kollar, Laura, Clancy-Oliveri, Mary, Basu, Rita, Kovatchev, Boris, Basu, Ananda
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mary Ann Liebert, Inc., publishers 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464084/ https://www.ncbi.nlm.nih.gov/pubmed/35255229 http://dx.doi.org/10.1089/dia.2021.0542

Ejemplares similares

Biobehavioral Changes Following Transition to Automated Insulin Delivery: A Large Real-life Database Analysis
por: Kovatchev, Boris P., et al.
Publicado: (2022)

Automated closed-loop control of diabetes: the artificial pancreas
por: Kovatchev, Boris
Publicado: (2018)

Effects of Type 2 Diabetes on Insulin Secretion, Insulin Action, Glucose Effectiveness, and Postprandial Glucose Metabolism
por: Basu, Ananda, et al.
Publicado: (2009)

Assessment of Meal Anticipation for Improving Fully Automated Insulin Delivery in Adults With Type 1 Diabetes
por: Garcia-Tirado, Jose, et al.
Publicado: (2023)

Association of Basal Hyperglucagonemia with Impaired Glucagon Counterregulation in Type 1 Diabetes
por: Farhy, Leon S., et al.
Publicado: (2012)

Greater early postprandial suppression of endogenous glucose production and higher initial glucose disappearance is achieved with fast‐acting insulin aspart compared with insulin aspart
por: Basu, Ananda, et al.
Publicado: (2018)

Insulin glargine/lixisenatide fixed‐ratio combination improves glycaemic variability and control without increasing hypoglycaemia
por: Aronson, Ronnie, et al.
Publicado: (2018)

Diurnal Pattern to Insulin Secretion and Insulin Action in Healthy Individuals
por: Saad, Ahmed, et al.
Publicado: (2012)

GPR40 Modulators: New Kid on the Block
por: Basu, Ananda, et al.
Publicado: (2013)

Quantitative Estimation of Insulin Sensitivity in Type 1 Diabetic Subjects Wearing a Sensor-Augmented Insulin Pump
por: Schiavon, Michele, et al.
Publicado: (2014)

Prandial Insulin and the Systemic Appearance of Meal-Derived Glucose in People With Type 1 Diabetes
por: Vella, Adrian, et al.
Publicado: (2008)

Consensus Recommendations for the Use of Automated Insulin Delivery Technologies in Clinical Practice
por: Phillip, Moshe, et al.
Publicado: (2022)

Effect of Automated Bio-Behavioral Feedback on the Control of Type 1 Diabetes
por: Kovatchev, Boris P., et al.
Publicado: (2011)

Interstitial Fluid Glucose Is Not Just a Shifted-in-Time but a Distorted Mirror of Blood Glucose: Insight from an In Silico Study
por: Cobelli, Claudio, et al.
Publicado: (2016)

Low Blood Glucose Index and Hypoglycaemia Risk: Insulin Glargine 300 U/mL Versus Insulin Glargine 100 U/mL in Type 2 Diabetes
por: Kovatchev, Boris, et al.
Publicado: (2020)

Sotagliflozin, a Dual SGLT1 and SGLT2 Inhibitor, as Adjunct Therapy to Insulin in Type 1 Diabetes
por: Sands, Arthur T., et al.
Publicado: (2015)

Open source automated insulin delivery: addressing the challenge
por: Oliver, Nick, et al.
Publicado: (2019)

AID(„automated insulin delivery“)-Systeme in der Diabetologie
por: Biester, Torben, et al.
Publicado: (2021)

Anti-inflammatory effect of SGLT-2 inhibitors via uric acid and insulin
por: La Grotta, Rosalba, et al.
Publicado: (2022)

Closed-Loop Artificial Pancreas Systems: Physiological Input to Enhance Next-Generation Devices
por: Kudva, Yogish C., et al.
Publicado: (2014)

Closed loop control for type 1 diabetes
por: Kovatchev, Boris
Publicado: (2011)

Diurnal Pattern of Insulin Action in Type 1 Diabetes: Implications for a Closed-Loop System
por: Hinshaw, Ling, et al.
Publicado: (2013)

Diabetes Technology: Markers, Monitoring, Assessment, and Control of Blood Glucose Fluctuations in Diabetes
por: Kovatchev, Boris P.
Publicado: (2012)

Automated Insulin Delivery: Easy Enough to Use in Primary Care?
por: Heile, Michael, et al.
Publicado: (2020)

Additional Evidence That Transaldolase Exchange, Isotope Discrimination During the Triose-Isomerase Reaction, or Both Occur in Humans: Effects of Type 2 Diabetes
por: Basu, Rita, et al.
Publicado: (2009)

SGLT2i: beyond the glucose-lowering effect
por: Ni, Lihua, et al.
Publicado: (2020)

Mineral and Electrolyte Disorders With SGLT2i Therapy
por: Cianciolo, Giuseppe, et al.
Publicado: (2019)

Intelligent Control with Artificial Neural Networks for Automated Insulin Delivery Systems
por: de Farias, João Lucas Correia Barbosa, et al.
Publicado: (2022)

The changing landscape of automated insulin delivery in the management of type 1 diabetes
por: Lakshman, Rama, et al.
Publicado: (2023)

Swimming With the Omnipod 5 Automated Insulin Delivery System: Connectivity in the Water
por: Hughes, Michael S., et al.
Publicado: (2023)

Insulin inhibits glucagon release by SGLT2-induced stimulation of somatostatin secretion
por: Vergari, Elisa, et al.
Publicado: (2019)

SGLT2 inhibitors for genetic and acquired insulin resistance: Considerations for clinical use
por: Hosokawa, Yusei, et al.
Publicado: (2020)

Perspective of SGLT2i in the Treatment of Abdominal Aortic Aneurysms
por: Jin, Zhongtiao, et al.
Publicado: (2023)

What End Users and Stakeholders Want From Automated Insulin Delivery Systems
por: Naranjo, Diana, et al.
Publicado: (2017)

Feasibility of automated insulin delivery guided by continuous glucose monitoring in preterm infants
por: Beardsall, Kathryn, et al.
Publicado: (2020)

Performance of an Automated Insulin Delivery System: Results of Early Phase Feasibility Studies
por: Christiansen, Mark, et al.
Publicado: (2021)

The Psychological Implications of Automated Insulin Delivery Systems in Type 1 Diabetes Care
por: Nefs, Giesje
Publicado: (2022)

Telemedicine Mediated Service Delivery for Substance Use Disorders
por: Basu, D
Publicado: (2022)

Precipitation of Euglycemic DKA (euDKA) From the Initiation of SGLT2 Inhibitor (SGLT2i) and 0-Carb Diet Inpatient
por: Popli, Rakesh, et al.
Publicado: (2021)

Practical aspects of diabetes technology use: Continuous glucose monitors, insulin pumps, and automated insulin delivery systems
por: Marks, Brynn E., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dv9js67uhqs7vqngov9p9kl8j8